speb/financial-data huggingface dataset:
NMP balance_sheet (quarterly, 2025-06-30) — Receivables: 4239.00
NMP balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -188456.00
NMP balance_sheet (quarterly, 2025-06-30) — Share Issued: 14403333.00
NMP cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 124793.00
NMP balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -159217.00
NMP balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -159217.00
NMP income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
NMP income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
NMP balance_sheet (quarterly, 2025-06-30) — Total Assets: 1569092.00
NMP balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -159217.00
NMP balance_sheet (quarterly, 2025-06-30) — Total Debt: 155093.00
NMP balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -159217.00
NMP income_statement (quarterly, 2025-06-30) — Total Expenses: 77889.00
NMP balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1728309.00
NMP balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 0.00
NMP balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
NMP balance_sheet (quarterly, 2025-06-30) — Working Capital: -159217.00
NMP income_statement (quarterly, 2025-09-30) — +Operating Expense: 191047.00
NMP income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
NMP balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 100371.00
NMP balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 0.00
NMP income_statement (quarterly, 2025-09-30) — Basic Average Shares: 15570670.00
NMP income_statement (quarterly, 2025-09-30) — Basic EPS: 0.06
NMP cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1325110.00
NMP balance_sheet (quarterly, 2025-09-30) — Capital Stock: 116163447.00
NMP balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 440824.00
NMP balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 440824.00
NMP balance_sheet (quarterly, 2025-09-30) — Cash Financial: 440824.00
NMP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 114707349.00
NMP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -591636.00
NMP cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -198340.00
NMP cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 3505.00
NMP cash_flow (quarterly, 2025-09-30) — Change In Payable: -198340.00
NMP cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -194835.00
NMP cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -205754.00
NMP cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -400589.00
NMP cash_flow (quarterly, 2025-09-30) — Changes In Cash: -884286.00
NMP balance_sheet (quarterly, 2025-09-30) — Common Stock: 116163447.00
NMP balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 116729713.00
NMP balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 0.00
NMP balance_sheet (quarterly, 2025-09-30) — Current Assets: 672177.00
NMP balance_sheet (quarterly, 2025-09-30) — Current Debt: 5093.00
NMP balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 5093.00
NMP balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 105464.00
NMP income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 15570670.00
NMP income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.06
NMP income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 971953.00
NMP balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 0.00
NMP income_statement (quarterly, 2025-09-30) — EBIT: -191047.00
NMP income_statement (quarterly, 2025-09-30) — EBITDA: -191047.00
NMP cash_flow (quarterly, 2025-09-30) — End Cash Position: 440824.00
NMP cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 114707351.00
NMP cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -591637.00
NMP income_statement (quarterly, 2025-09-30) — Interest Income: 1163000.00
NMP income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 1163000.00
NMP balance_sheet (quarterly, 2025-09-30) — Invested Capital: 116734806.00
NMP cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
NMP income_statement (quarterly, 2025-09-30) — Net Income: 971953.00
NMP income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 971953.00
NMP income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 971953.00
NMP income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 971953.00
NMP income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 971953.00
NMP cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 971953.00
NMP income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 971953.00
NMP income_statement (quarterly, 2025-09-30) — Net Interest Income: 1163000.00
NMP cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
NMP income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 1163000.00
NMP cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -1917649.00
NMP cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 0.00
NMP balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 116729713.00
NMP income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -191047.00
NMP income_statement (quarterly, 2025-09-30) — Normalized Income: 971953.00
NMP cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -591637.00
NMP income_statement (quarterly, 2025-09-30) — Operating Income: -191047.00
NMP income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
NMP balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 15970833.00
NMP balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 5093.00
NMP balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 116163000.00
NMP income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 191047.00
NMP balance_sheet (quarterly, 2025-09-30) — Payables: 100371.00
NMP balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 100371.00
NMP balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
NMP balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 231353.00
NMP income_statement (quarterly, 2025-09-30) — Pretax Income: 971953.00
NMP balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 566266.00
NMP balance_sheet (quarterly, 2025-09-30) — Share Issued: 15970833.00
NMP cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 0.00
NMP balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 116729713.00
NMP balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 116729713.00
NMP income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
NMP income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
NMP balance_sheet (quarterly, 2025-09-30) — Total Assets: 116835177.00
NMP balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 116729713.00
NMP balance_sheet (quarterly, 2025-09-30) — Total Debt: 5093.00
NMP balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 116729713.00
NMP income_statement (quarterly, 2025-09-30) — Total Expenses: 191047.00
NMP balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 105464.00
NMP balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 116163000.00
NMP balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
NMP balance_sheet (quarterly, 2025-09-30) — Working Capital: 566713.00
NMP income_statement (annual, 2025-12-31) — +Operating Expense: 504922.00
NMP income_statement (quarterly, 2025-12-31) — +Operating Expense: 180419.00
NMP income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
NMP income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
NMP balance_sheet (annual, 2025-12-31) — Accounts Payable: 122954.00
NMP balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 122954.00
NMP balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 0.00
NMP balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 0.00
NMP income_statement (annual, 2025-12-31) — Basic Average Shares: 9714571.00
NMP income_statement (annual, 2025-12-31) — Basic EPS: 0.18
NMP cash_flow (annual, 2025-12-31) — Beginning Cash Position: 0.00
NMP cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 440824.00
NMP balance_sheet (annual, 2025-12-31) — Capital Stock: 116884046.00
NMP balance_sheet (quarterly, 2025-12-31) — Capital Stock: 116884046.00
NMP balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 353247.00
NMP balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 353247.00
NMP balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 353247.00
NMP balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 353247.00
NMP balance_sheet (annual, 2025-12-31) — Cash Financial: 353247.00
NMP balance_sheet (quarterly, 2025-12-31) — Cash Financial: 353247.00
NMP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 115895878.00
NMP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 3660.00
NMP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -115000000.00
NMP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
NMP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -542631.00
NMP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -91237.00
NMP cash_flow (annual, 2025-12-31) — Change In Account Payable: 122954.00
NMP cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 22583.00
NMP cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -17500.00
NMP cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -3792.00
NMP cash_flow (annual, 2025-12-31) — Change In Payable: 122954.00
NMP cash_flow (quarterly, 2025-12-31) — Change In Payable: 22583.00
NMP cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 105454.00
NMP cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 18791.00
NMP cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -143163.00
NMP cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 70391.00
NMP cash_flow (annual, 2025-12-31) — Change In Working Capital: -37709.00
NMP cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 89182.00
NMP cash_flow (annual, 2025-12-31) — Changes In Cash: 353247.00
NMP cash_flow (quarterly, 2025-12-31) — Changes In Cash: -87577.00
NMP balance_sheet (annual, 2025-12-31) — Common Stock: 116884046.00
NMP balance_sheet (quarterly, 2025-12-31) — Common Stock: 116884046.00
NMP balance_sheet (annual, 2025-12-31) — Common Stock Equity: 117669892.00
NMP balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 117669892.00
NMP cash_flow (annual, 2025-12-31) — Common Stock Issuance: 116625000.00
NMP cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
NMP balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 0.00
NMP balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 0.00
NMP balance_sheet (annual, 2025-12-31) — Current Assets: 514210.00
NMP balance_sheet (quarterly, 2025-12-31) — Current Assets: 514210.00
NMP balance_sheet (annual, 2025-12-31) — Current Debt: 4963.00
NMP balance_sheet (quarterly, 2025-12-31) — Current Debt: 4963.00
NMP balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 4963.00
NMP balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 4963.00
NMP balance_sheet (annual, 2025-12-31) — Current Liabilities: 127917.00
NMP balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 127917.00
NMP income_statement (annual, 2025-12-31) — Diluted Average Shares: 9714571.00
NMP income_statement (annual, 2025-12-31) — Diluted EPS: 0.18
NMP income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1778677.00
NMP income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 940180.00
NMP balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 0.00
NMP balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 0.00
NMP income_statement (annual, 2025-12-31) — EBIT: -504922.00
NMP income_statement (quarterly, 2025-12-31) — EBIT: -180419.00
NMP income_statement (annual, 2025-12-31) — EBITDA: -504922.00
NMP income_statement (quarterly, 2025-12-31) — EBITDA: -180419.00
NMP cash_flow (annual, 2025-12-31) — End Cash Position: 353247.00
NMP cash_flow (quarterly, 2025-12-31) — End Cash Position: 353247.00
NMP cash_flow (annual, 2025-12-31) — Financing Cash Flow: 115895878.00
NMP cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 3660.00
NMP cash_flow (annual, 2025-12-31) — Free Cash Flow: -542631.00
NMP cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -91237.00
NMP cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -2283599.00
NMP cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -1120599.00
NMP income_statement (annual, 2025-12-31) — Interest Income: 2283599.00
NMP income_statement (quarterly, 2025-12-31) — Interest Income: 1120599.00
NMP income_statement (annual, 2025-12-31) — Interest Income Non Operating: 2283599.00
NMP income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1120599.00
NMP balance_sheet (annual, 2025-12-31) — Invested Capital: 117674855.00
NMP balance_sheet (quarterly, 2025-12-31) — Invested Capital: 117674855.00
NMP cash_flow (annual, 2025-12-31) — Investing Cash Flow: -115000000.00
NMP cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 0.00
NMP cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 116625000.00
NMP cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
NMP cash_flow (annual, 2025-12-31) — Issuance Of Debt: 124663.00
NMP cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -130.00
NMP cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 116625000.00
NMP cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
NMP income_statement (annual, 2025-12-31) — Net Income: 1778677.00
NMP income_statement (quarterly, 2025-12-31) — Net Income: 940180.00
NMP income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 1778677.00
NMP income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 940180.00
NMP income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 1778677.00
NMP income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 940180.00
NMP income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1778677.00
NMP income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 940180.00
NMP income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1778677.00
NMP income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 940180.00
NMP cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 1778677.00
NMP cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 940180.00
NMP income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 1778677.00
NMP income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 940180.00
NMP income_statement (annual, 2025-12-31) — Net Interest Income: 2283599.00
NMP income_statement (quarterly, 2025-12-31) — Net Interest Income: 1120599.00
NMP cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 124663.00
NMP cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -130.00
NMP income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 2283599.00
NMP income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 1120599.00
NMP cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -853785.00
NMP cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 3790.00
NMP cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -115000000.00
NMP cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
NMP cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 124663.00
NMP cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -130.00
NMP balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 117669892.00
NMP balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 117669892.00
NMP income_statement (annual, 2025-12-31) — Normalized EBITDA: -504922.00
NMP income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -180419.00
NMP income_statement (annual, 2025-12-31) — Normalized Income: 1778677.00
NMP income_statement (quarterly, 2025-12-31) — Normalized Income: 940180.00
NMP cash_flow (annual, 2025-12-31) — Operating Cash Flow: -542631.00
NMP cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -91237.00
NMP cash_flow (annual, 2025-12-31) — Operating Gains Losses: -2283599.00
NMP cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -1120599.00
NMP income_statement (annual, 2025-12-31) — Operating Income: -504922.00
NMP income_statement (quarterly, 2025-12-31) — Operating Income: -180419.00
NMP income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
NMP income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
NMP balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 15970833.00
NMP balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 15970833.00
NMP balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 4963.00
NMP balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 4963.00
NMP balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 117283599.00
NMP balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 117283599.00
NMP income_statement (annual, 2025-12-31) — Other Operating Expenses: 504922.00
NMP income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 180419.00
NMP balance_sheet (annual, 2025-12-31) — Payables: 122954.00
NMP balance_sheet (quarterly, 2025-12-31) — Payables: 122954.00
NMP balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 122954.00
NMP balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 122954.00
NMP balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
NMP balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
NMP balance_sheet (annual, 2025-12-31) — Prepaid Assets: 160963.00
NMP balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 160963.00
NMP income_statement (annual, 2025-12-31) — Pretax Income: 1778677.00
NMP income_statement (quarterly, 2025-12-31) — Pretax Income: 940180.00
NMP balance_sheet (annual, 2025-12-31) — Retained Earnings: 785846.00
NMP balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 785846.00
NMP balance_sheet (annual, 2025-12-31) — Share Issued: 15970833.00
NMP balance_sheet (quarterly, 2025-12-31) — Share Issued: 15970833.00
NMP cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 124663.00
NMP cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: -130.00
NMP balance_sheet (annual, 2025-12-31) — Stockholders Equity: 117669892.00
NMP balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 117669892.00
NMP balance_sheet (annual, 2025-12-31) — Tangible Book Value: 117669892.00
NMP balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 117669892.00
NMP income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
NMP income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
NMP income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
NMP income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
NMP balance_sheet (annual, 2025-12-31) — Total Assets: 117797809.00
NMP balance_sheet (quarterly, 2025-12-31) — Total Assets: 117797809.00
NMP balance_sheet (annual, 2025-12-31) — Total Capitalization: 117669892.00
NMP balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 117669892.00
NMP balance_sheet (annual, 2025-12-31) — Total Debt: 4963.00
NMP balance_sheet (quarterly, 2025-12-31) — Total Debt: 4963.00
NMP balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 117669892.00
NMP balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 117669892.00
NMP income_statement (annual, 2025-12-31) — Total Expenses: 504922.00
NMP income_statement (quarterly, 2025-12-31) — Total Expenses: 180419.00
NMP balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 127917.00
NMP balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 127917.00
NMP balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 117283599.00
NMP balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 117283599.00
NMP balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
NMP balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
NMP balance_sheet (annual, 2025-12-31) — Working Capital: 386293.00
NMP balance_sheet (quarterly, 2025-12-31) — Working Capital: 386293.00
NMP income_statement (quarterly, 2026-03-31) — +Operating Expense: 438200.00
NMP income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
NMP balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 327210.00
NMP balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 0.00
NMP income_statement (quarterly, 2026-03-31) — Basic Average Shares: 15970833.00
NMP income_statement (quarterly, 2026-03-31) — Basic EPS: 0.04
NMP cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 353247.00
NMP balance_sheet (quarterly, 2026-03-31) — Capital Stock: 117915313.00
NMP balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 156475.00
NMP balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 156475.00
NMP balance_sheet (quarterly, 2026-03-31) — Cash Financial: 156475.00
NMP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -196772.00
NMP cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 204256.00
NMP cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 72025.00
NMP cash_flow (quarterly, 2026-03-31) — Change In Payable: 204256.00
NMP cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 276281.00
NMP cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -34853.00
NMP cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 241428.00
NMP cash_flow (quarterly, 2026-03-31) — Changes In Cash: -196772.00
NMP balance_sheet (quarterly, 2026-03-31) — Common Stock: 117915313.00
NMP balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 118262959.00
NMP balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 72025.00
NMP balance_sheet (quarterly, 2026-03-31) — Current Assets: 352291.00
NMP balance_sheet (quarterly, 2026-03-31) — Current Debt: 4963.00
NMP balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 4963.00
NMP balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 404198.00
NMP income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 15970833.00
NMP income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.04
NMP income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 593067.00
NMP income_statement (quarterly, 2026-03-31) — EBIT: -438200.00
NMP income_statement (quarterly, 2026-03-31) — EBITDA: -438200.00
NMP cash_flow (quarterly, 2026-03-31) — End Cash Position: 156475.00
NMP cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -196772.00
NMP cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -1031267.00
NMP income_statement (quarterly, 2026-03-31) — Interest Income: 1031267.00
NMP income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1031267.00
NMP balance_sheet (quarterly, 2026-03-31) — Invested Capital: 118267922.00
NMP income_statement (quarterly, 2026-03-31) — Net Income: 593067.00
NMP income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 593067.00
NMP income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 593067.00
NMP income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 593067.00
NMP income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 593067.00
NMP cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 593067.00
NMP income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 593067.00
NMP income_statement (quarterly, 2026-03-31) — Net Interest Income: 1031267.00
NMP income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 1031267.00
NMP balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 118262959.00
NMP income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -438200.00
NMP income_statement (quarterly, 2026-03-31) — Normalized Income: 593067.00
NMP cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -196772.00
NMP cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -1031267.00
NMP income_statement (quarterly, 2026-03-31) — Operating Income: -438200.00
NMP income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
NMP balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 15970833.00
NMP balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 4963.00
NMP balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 118314866.00
NMP income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 438200.00
NMP balance_sheet (quarterly, 2026-03-31) — Payables: 327210.00
NMP balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 399235.00
NMP balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
NMP balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 195816.00
NMP income_statement (quarterly, 2026-03-31) — Pretax Income: 593067.00
NMP balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 347646.00
NMP balance_sheet (quarterly, 2026-03-31) — Share Issued: 15970833.00
NMP balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 118262959.00
NMP balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 118262959.00
NMP income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
NMP income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
NMP balance_sheet (quarterly, 2026-03-31) — Total Assets: 118667157.00
NMP balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 118262959.00
NMP balance_sheet (quarterly, 2026-03-31) — Total Debt: 4963.00
NMP balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 118262959.00
NMP income_statement (quarterly, 2026-03-31) — Total Expenses: 438200.00
NMP balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 404198.00
NMP balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 118314866.00
NMP balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
NMP balance_sheet (quarterly, 2026-03-31) — Working Capital: -51907.00
NMR income_statement (annual, 2022-03-31) — +Total Revenue: 1143717000000.00
NMR balance_sheet (annual, 2022-03-31) — Accounts Payable: 1522961000000.00
NMR balance_sheet (annual, 2022-03-31) — Accounts Receivable: 417661000000.00
NMR balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -426081000000.00
NMR balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 697507000000.00
NMR balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 849597000000.00
NMR income_statement (annual, 2022-03-31) — Average Dilution Earnings: -135000000.00
NMR income_statement (annual, 2022-03-31) — Basic Average Shares: 3063524091.00
NMR income_statement (annual, 2022-03-31) — Basic EPS: 46.68
NMR cash_flow (annual, 2022-03-31) — Beginning Cash Position: 3510011000000.00
NMR balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 60025000000.00
NMR cash_flow (annual, 2022-03-31) — Capital Expenditure: -111331000000.00
NMR balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 198131000000.00
NMR balance_sheet (annual, 2022-03-31) — Capital Stock: 594493000000.00
NMR balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 4063511000000.00
NMR balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Federal Funds Sold: 15942823000000.00
NMR cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -70714000000.00
NMR balance_sheet (annual, 2022-03-31) — Cash Financial: 3316238000000.00
NMR cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Financing Activities: 1112718000000.00
NMR cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Investing Activities: -593182000000.00
NMR cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Operating Activities: -862832000000.00
NMR cash_flow (annual, 2022-03-31) — Change In Account Payable: -247980000000.00
NMR cash_flow (annual, 2022-03-31) — Change In Accrued Expense: -1865000000.00
NMR cash_flow (annual, 2022-03-31) — Change In Income Tax Payable: -37639000000.00
NMR cash_flow (annual, 2022-03-31) — Change In Other Current Assets: 595116000000.00
NMR cash_flow (annual, 2022-03-31) — Change In Other Working Capital: 1521518000000.00
NMR cash_flow (annual, 2022-03-31) — Change In Payable: -285619000000.00
NMR cash_flow (annual, 2022-03-31) — Change In Payables And Accrued Expense: -287484000000.00
NMR cash_flow (annual, 2022-03-31) — Change In Tax Payable: -37639000000.00
NMR cash_flow (annual, 2022-03-31) — Change In Working Capital: -874991000000.00
NMR cash_flow (annual, 2022-03-31) — Changes In Cash: -343296000000.00
NMR balance_sheet (annual, 2022-03-31) — Commercial Paper: 131915000000.00
NMR balance_sheet (annual, 2022-03-31) — Common Stock: 594493000000.00
NMR cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -70714000000.00
NMR balance_sheet (annual, 2022-03-31) — Common Stock Equity: 2914605000000.00
NMR cash_flow (annual, 2022-03-31) — Common Stock Issuance: 11000000.00
NMR cash_flow (annual, 2022-03-31) — Common Stock Payments: -39650000000.00
NMR balance_sheet (annual, 2022-03-31) — Construction In Progress: 7978000000.00
NMR balance_sheet (annual, 2022-03-31) — Current Accrued Expenses: 457511000000.00
NMR balance_sheet (annual, 2022-03-31) — Current Debt: 1050141000000.00
NMR balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 1050141000000.00
NMR cash_flow (annual, 2022-03-31) — Deferred Income Tax: 3106000000.00
NMR cash_flow (annual, 2022-03-31) — Deferred Tax: 3106000000.00
NMR cash_flow (annual, 2022-03-31) — Depreciation Amortization Depletion: 59524000000.00
NMR cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 59524000000.00
NMR income_statement (annual, 2022-03-31) — Diluted Average Shares: 3158708013.00
NMR income_statement (annual, 2022-03-31) — Diluted EPS: 45.23
NMR income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 142861000000.00
NMR cash_flow (annual, 2022-03-31) — Earnings Losses From Equity Investments: -20235000000.00
NMR cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: 149693000000.00
NMR cash_flow (annual, 2022-03-31) — End Cash Position: 3316408000000.00
NMR cash_flow (annual, 2022-03-31) — Financing Cash Flow: 1112718000000.00
NMR cash_flow (annual, 2022-03-31) — Free Cash Flow: -974163000000.00
NMR cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -5446000000.00
NMR cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of Business: -79396000000.00
NMR cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: -3490000000.00
NMR income_statement (annual, 2022-03-31) — Gain On Sale Of Business: 79396000000.00
NMR income_statement (annual, 2022-03-31) — Gain On Sale Of Security: 36214000000.00
NMR balance_sheet (annual, 2022-03-31) — Gains Losses Not Affecting Retained Earnings: 127973000000.00
NMR income_statement (annual, 2022-03-31) — General And Administrative Expense: 529506000000.00
NMR balance_sheet (annual, 2022-03-31) — Goodwill: 14407000000.00
NMR balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 30007000000.00
NMR balance_sheet (annual, 2022-03-31) — Gross PPE: 845128000000.00
NMR cash_flow (annual, 2022-03-31) — Income Tax Paid Supplemental Data: 114623000000.00
NMR balance_sheet (annual, 2022-03-31) — Income Tax Payable: 34158000000.00
NMR income_statement (annual, 2022-03-31) — Interest Expense: 230109000000.00
NMR income_statement (annual, 2022-03-31) — Interest Income: 284222000000.00
NMR cash_flow (annual, 2022-03-31) — Interest Paid Supplemental Data: 225679000000.00
NMR balance_sheet (annual, 2022-03-31) — Invested Capital: 13619343000000.00
NMR cash_flow (annual, 2022-03-31) — Investing Cash Flow: -593182000000.00
NMR balance_sheet (annual, 2022-03-31) — Investments And Advances: 11861438000000.00
NMR cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 11000000.00
NMR cash_flow (annual, 2022-03-31) — Issuance Of Debt: 5682108000000.00
NMR balance_sheet (annual, 2022-03-31) — Land And Improvements: 39118000000.00
NMR balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 198131000000.00
NMR balance_sheet (annual, 2022-03-31) — Long Term Debt: 9654597000000.00
NMR balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 9852728000000.00
NMR cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 3938291000000.00
NMR cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -2656233000000.00
NMR balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 424436000000.00
NMR balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 104609000000.00
NMR balance_sheet (annual, 2022-03-31) — Minority Interest: 58198000000.00
NMR income_statement (annual, 2022-03-31) — Minority Interests: -3537000000.00
NMR cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: 0.00
NMR cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: -39639000000.00
NMR balance_sheet (annual, 2022-03-31) — Net Debt: 6641227000000.00
NMR income_statement (annual, 2022-03-31) — Net Income: 142996000000.00
NMR income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 142996000000.00
NMR income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 146533000000.00
NMR income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 142996000000.00
NMR income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 142996000000.00
NMR cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 146533000000.00
NMR income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 146533000000.00
NMR income_statement (annual, 2022-03-31) — Net Interest Income: 54113000000.00
NMR cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 90319000000.00
NMR cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 861777000000.00
NMR cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 1282058000000.00
NMR cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -11281000000.00
NMR cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -4466000000.00
NMR balance_sheet (annual, 2022-03-31) — Net PPE: 419047000000.00
NMR cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -16346000000.00
NMR cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: -420281000000.00
NMR balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 2884598000000.00
NMR income_statement (annual, 2022-03-31) — Normalized Income: 89368758000.00
NMR income_statement (annual, 2022-03-31) — Occupancy And Equipment: 69742000000.00
NMR cash_flow (annual, 2022-03-31) — Operating Cash Flow: -862832000000.00
NMR cash_flow (annual, 2022-03-31) — Operating Gains Losses: -108567000000.00
NMR income_statement (annual, 2022-03-31) — Operating Revenue: 1143717000000.00
NMR balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 3017804012.00
NMR balance_sheet (annual, 2022-03-31) — Other Current Borrowings: 918226000000.00
NMR income_statement (annual, 2022-03-31) — Other Gand A: 199960000000.00
NMR balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 15600000000.00
NMR cash_flow (annual, 2022-03-31) — Other Non Cash Items: -125127000000.00
NMR income_statement (annual, 2022-03-31) — Other Non Interest Expense: 432815000000.00
NMR balance_sheet (annual, 2022-03-31) — Other Payable: 1636725000000.00
NMR balance_sheet (annual, 2022-03-31) — Other Properties: 207317000000.00
NMR balance_sheet (annual, 2022-03-31) — Other Receivables: 1295878000000.00
NMR income_statement (annual, 2022-03-31) — Other Special Charges: -3490000000.00
NMR balance_sheet (annual, 2022-03-31) — Payables: 3193844000000.00
NMR balance_sheet (annual, 2022-03-31) — Payables And Accrued Expenses: 3651355000000.00
NMR balance_sheet (annual, 2022-03-31) — Prepaid Assets: 17165000000.00
NMR income_statement (annual, 2022-03-31) — Pretax Income: 226623000000.00
NMR cash_flow (annual, 2022-03-31) — Purchase Of Business: 0.00
NMR cash_flow (annual, 2022-03-31) — Purchase Of Investment: -115206000000.00
NMR cash_flow (annual, 2022-03-31) — Purchase Of PPE: -111331000000.00
NMR balance_sheet (annual, 2022-03-31) — Receivables: 1713539000000.00
NMR income_statement (annual, 2022-03-31) — Reconciled Depreciation: 59524000000.00
NMR cash_flow (annual, 2022-03-31) — Repayment Of Debt: -4820331000000.00
NMR cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: -39650000000.00
NMR balance_sheet (annual, 2022-03-31) — Retained Earnings: 1606987000000.00
NMR income_statement (annual, 2022-03-31) — Salaries And Wages: 529506000000.00
NMR cash_flow (annual, 2022-03-31) — Sale Of Business: 0.00
NMR cash_flow (annual, 2022-03-31) — Sale Of Investment: 205525000000.00
NMR cash_flow (annual, 2022-03-31) — Sale Of PPE: 94985000000.00
NMR income_statement (annual, 2022-03-31) — Selling General And Administration: 529506000000.00
NMR balance_sheet (annual, 2022-03-31) — Share Issued: 3233562601.00
NMR cash_flow (annual, 2022-03-31) — Short Term Debt Issuance: 1743817000000.00
NMR cash_flow (annual, 2022-03-31) — Short Term Debt Payments: -2164098000000.00
NMR income_statement (annual, 2022-03-31) — Special Income Charges: 82886000000.00
NMR cash_flow (annual, 2022-03-31) — Stock Based Compensation: 27941000000.00
NMR balance_sheet (annual, 2022-03-31) — Stockholders Equity: 2914605000000.00
NMR balance_sheet (annual, 2022-03-31) — Tangible Book Value: 2884598000000.00
NMR income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 29258758000.00
NMR income_statement (annual, 2022-03-31) — Tax Provision: 80090000000.00
NMR income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.35
NMR balance_sheet (annual, 2022-03-31) — Total Assets: 43412156000000.00
NMR balance_sheet (annual, 2022-03-31) — Total Capitalization: 12569202000000.00
NMR balance_sheet (annual, 2022-03-31) — Total Debt: 10902869000000.00
NMR balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 2972803000000.00
NMR balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 40439353000000.00
NMR balance_sheet (annual, 2022-03-31) — Total Tax Payable: 34158000000.00
NMR income_statement (annual, 2022-03-31) — Total Unusual Items: 82886000000.00
NMR income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 82886000000.00
NMR balance_sheet (annual, 2022-03-31) — Trading Securities: 10587405000000.00
NMR balance_sheet (annual, 2022-03-31) — Treasury Shares Number: 215758589.00
NMR balance_sheet (annual, 2022-03-31) — Treasury Stock: 112355000000.00
NMR income_statement (annual, 2023-03-31) — +Total Revenue: 1144971000000.00
NMR balance_sheet (annual, 2023-03-31) — Accounts Payable: 1359948000000.00
NMR balance_sheet (annual, 2023-03-31) — Accounts Receivable: 379911000000.00
NMR balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -459954000000.00
NMR balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 707189000000.00
NMR balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 683933000000.00
NMR income_statement (annual, 2023-03-31) — Average Dilution Earnings: -180000000.00
NMR income_statement (annual, 2023-03-31) — Basic Average Shares: 3006744201.00
NMR income_statement (annual, 2023-03-31) — Basic EPS: 30.86
NMR cash_flow (annual, 2023-03-31) — Beginning Cash Position: 3316408000000.00
NMR cash_flow (annual, 2023-03-31) — Capital Expenditure: -171165000000.00
NMR balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 193883000000.00
NMR balance_sheet (annual, 2023-03-31) — Capital Stock: 594493000000.00
NMR balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 4521247000000.00
NMR balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Federal Funds Sold: 18355707000000.00
NMR cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -57262000000.00
NMR balance_sheet (annual, 2023-03-31) — Cash Financial: 3820685000000.00
NMR cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Financing Activities: 1283937000000.00
NMR cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Investing Activities: -233225000000.00
NMR cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Operating Activities: -694820000000.00
NMR cash_flow (annual, 2023-03-31) — Change In Account Payable: -139417000000.00
NMR cash_flow (annual, 2023-03-31) — Change In Accrued Expense: -3319000000.00
NMR cash_flow (annual, 2023-03-31) — Change In Income Tax Payable: -42603000000.00
NMR cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 834438000000.00
NMR cash_flow (annual, 2023-03-31) — Change In Other Working Capital: -150710000000.00
NMR cash_flow (annual, 2023-03-31) — Change In Payable: -182020000000.00
NMR cash_flow (annual, 2023-03-31) — Change In Payables And Accrued Expense: -185339000000.00
NMR cash_flow (annual, 2023-03-31) — Change In Tax Payable: -42603000000.00
NMR cash_flow (annual, 2023-03-31) — Change In Working Capital: -453662000000.00
NMR cash_flow (annual, 2023-03-31) — Changes In Cash: 355892000000.00
NMR balance_sheet (annual, 2023-03-31) — Commercial Paper: 299993000000.00
NMR balance_sheet (annual, 2023-03-31) — Common Stock: 594493000000.00
NMR cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -57262000000.00
NMR balance_sheet (annual, 2023-03-31) — Common Stock Equity: 3148567000000.00
NMR cash_flow (annual, 2023-03-31) — Common Stock Issuance: 4000000.00
NMR cash_flow (annual, 2023-03-31) — Common Stock Payments: -24728000000.00
NMR balance_sheet (annual, 2023-03-31) — Current Accrued Expenses: 479491000000.00
NMR balance_sheet (annual, 2023-03-31) — Current Debt: 1008541000000.00
NMR balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 1008541000000.00
NMR cash_flow (annual, 2023-03-31) — Deferred Income Tax: 6137000000.00
NMR cash_flow (annual, 2023-03-31) — Deferred Tax: 6137000000.00
NMR cash_flow (annual, 2023-03-31) — Depreciation Amortization Depletion: 61424000000.00
NMR cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 61424000000.00
NMR income_statement (annual, 2023-03-31) — Diluted Average Shares: 3119905851.00
NMR income_statement (annual, 2023-03-31) — Diluted EPS: 29.74
NMR income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 92606000000.00
NMR cash_flow (annual, 2023-03-31) — Earnings Losses From Equity Investments: -34127000000.00
NMR cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 148552000000.00
NMR cash_flow (annual, 2023-03-31) — End Cash Position: 3820852000000.00
NMR cash_flow (annual, 2023-03-31) — Financing Cash Flow: 1283937000000.00
NMR cash_flow (annual, 2023-03-31) — Free Cash Flow: -865985000000.00
NMR cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 1426000000.00
NMR cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of Business: -23889000000.00
NMR cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 344000000.00
NMR income_statement (annual, 2023-03-31) — Gain On Sale Of Business: 23889000000.00
NMR income_statement (annual, 2023-03-31) — Gain On Sale Of Security: 13078000000.00
NMR balance_sheet (annual, 2023-03-31) — Gains Losses Not Affecting Retained Earnings: 318454000000.00
NMR income_statement (annual, 2023-03-31) — General And Administrative Expense: 605787000000.00
NMR balance_sheet (annual, 2023-03-31) — Goodwill: 17638000000.00
NMR balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 36194000000.00
NMR balance_sheet (annual, 2023-03-31) — Gross PPE: 924270000000.00
NMR cash_flow (annual, 2023-03-31) — Income Tax Paid Supplemental Data: 94263000000.00
NMR balance_sheet (annual, 2023-03-31) — Income Tax Payable: 42254000000.00
NMR income_statement (annual, 2023-03-31) — Interest Expense: 1151149000000.00
NMR income_statement (annual, 2023-03-31) — Interest Income: 1114690000000.00
NMR cash_flow (annual, 2023-03-31) — Interest Paid Supplemental Data: 1098815000000.00
NMR balance_sheet (annual, 2023-03-31) — Invested Capital: 14890637000000.00
NMR cash_flow (annual, 2023-03-31) — Investing Cash Flow: -233225000000.00
NMR balance_sheet (annual, 2023-03-31) — Investments And Advances: 13033467000000.00
NMR cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 4000000.00
NMR cash_flow (annual, 2023-03-31) — Issuance Of Debt: 4886702000000.00
NMR balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 193883000000.00
NMR balance_sheet (annual, 2023-03-31) — Long Term Debt: 10733529000000.00
NMR balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 10927412000000.00
NMR cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 2256619000000.00
NMR cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -1168086000000.00
NMR balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 496226000000.00
NMR balance_sheet (annual, 2023-03-31) — Minority Interest: 75575000000.00
NMR income_statement (annual, 2023-03-31) — Minority Interests: 1110000000.00
NMR cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 16950000000.00
NMR cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: -24724000000.00
NMR balance_sheet (annual, 2023-03-31) — Net Debt: 7220823000000.00
NMR income_statement (annual, 2023-03-31) — Net Income: 92786000000.00
NMR income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 92786000000.00
NMR income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 91676000000.00
NMR income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 92786000000.00
NMR income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 92786000000.00
NMR cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 91676000000.00
NMR income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 91676000000.00
NMR income_statement (annual, 2023-03-31) — Net Interest Income: -36459000000.00
NMR cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 225566000000.00
NMR cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 1024028000000.00
NMR cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 1088533000000.00
NMR cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 13028000000.00
NMR cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -8978000000.00
NMR balance_sheet (annual, 2023-03-31) — Net PPE: 464316000000.00
NMR cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -107517000000.00
NMR cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -64505000000.00
NMR balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 3112373000000.00
NMR balance_sheet (annual, 2023-03-31) — Non Current Deferred Liabilities: 93834000000.00
NMR balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 93834000000.00
NMR income_statement (annual, 2023-03-31) — Normalized Income: 78352915000.00
NMR income_statement (annual, 2023-03-31) — Occupancy And Equipment: 66857000000.00
NMR cash_flow (annual, 2023-03-31) — Operating Cash Flow: -694820000000.00
NMR cash_flow (annual, 2023-03-31) — Operating Gains Losses: -56246000000.00